AI Native Case Study #42: Genmab

👏 Genmab, a leader in biotechnology, is revolutionizing cancer treatment through transformative antibody therapies by integrating AI extensively into their operations.

🌟 Background
Genmab specializes in next-generation antibody therapies for serious diseases, aiming to enhance patient care with its innovative KYSO® treatments.

🏔️ Challenge
With a recent tripling in size, Genmab faced operational challenges in managing complex scientific data and sought to leverage AI for improved efficiency.

💡 Solution
Genmab launched a collaboration with ChatGPT, providing over 2,000 employees access to AI tools. They encouraged everyone to experiment with ChatGPT by integrating it into daily tasks, effectively scaling its usage.

🚀 Benefit
📈 Increased productivity: Employees saved an average of 3.5 hours per week by utilizing ChatGPT.
🔍 Enhanced research capabilities: Over 100 custom GPTs were developed to streamline processes like document drafting and data analysis.
⚙️ Faster translations: The AI Translator GPT reduced translation times from weeks to hours, showcasing significant cost savings.

📊 Evaluation
Ethical AI: (9/10) Genmab ensures compliance, security, and responsible use of AI technologies.
AI Native: (8/10) Genmab integrates AI deeply into various operations, enhancing productivity and innovation.
Application Modernization: (9/10) The company transforms workflows and documentation processes using advanced AI tools.

#AIinBiotech #Innovation #OpenAI #EthicalAI #AINative #AppModernization

Statement:
1) This case is sourced from OpenAI’s official website, linked to https://openai.com/index/genmab/.
2) Evaluation results are generated by AI, lack of data support, reference learning only.

That’s all for today’s Global AI Native Industry Insights. Join us at AI Native Foundation Membership Dashboard for the latest insights on AI Native, or follow our linkedin account at AI Native Foundation and our twitter account at AINativeF.